These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 2955547
21. Adverse reactions to pyrimethamine/sulfadoxine. Koch-Weser J, Hodel C, Leimer R, Styk S. Lancet; 1982 Dec 25; 2(8313):1459. PubMed ID: 6129527 [No Abstract] [Full Text] [Related]
24. Treatment failure of falciparum malaria with Fansidar in Tawau Sabah. January-June, 1982. Tan Heng Soon, Tan Puay Eng. Med J Malaysia; 1983 Sep 25; 38(3):217-23. PubMed ID: 6369092 [No Abstract] [Full Text] [Related]
25. Severe cutaneous adverse reactions to sulfadoxine-pyrimethamine in Switzerland. Steffen R, Somaini B. Lancet; 1986 Mar 15; 1(8481):610. PubMed ID: 2869315 [No Abstract] [Full Text] [Related]
26. Boxed warning added to Fansidar labeling. FDA Drug Bull; 1985 Aug 15; 15(2):21. PubMed ID: 4054454 [No Abstract] [Full Text] [Related]
27. Serious reactions during malaria prophylaxis with pyrimethamine-sulfadoxine. Olsen VV, Loft S, Christensen KD. Lancet; 1982 Oct 30; 2(8305):994. PubMed ID: 6127497 [No Abstract] [Full Text] [Related]
28. Stevens-Johnson syndrome due to pyrimethamine/sulfadoxine during presumptive self-therapy of malaria. Phillips-Howard PA, Behrens RH, Dunlop J. Lancet; 1989 Sep 30; 2(8666):803-4. PubMed ID: 2571042 [No Abstract] [Full Text] [Related]
29. Severe cutaneous adverse reactions and sulphadoxine-pyrimethamine in Sabah, Malaysia. Lyn PC, Fernandez E. Med J Aust; 1987 Mar 16; 146(6):335-6. PubMed ID: 2950306 [No Abstract] [Full Text] [Related]
30. [Pruritus, exanthema, icterus and fever]. Groth H, Rhyner K, Vetter W. Schweiz Rundsch Med Prax; 1987 May 12; 76(20):570-4. PubMed ID: 3629058 [No Abstract] [Full Text] [Related]
31. An unusual combination of phototoxicity and Stevens-Johnson syndrome due to antimalarial therapy. Ortel B, Sivayathorn A, Hönigsmann H. Dermatologica; 1989 May 12; 178(1):39-42. PubMed ID: 2917679 [Abstract] [Full Text] [Related]
32. Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis. Hellgren U, Rombo L, Berg B, Carlson J, Wiholm BE. Br Med J (Clin Res Ed); 1987 Aug 08; 295(6594):365-6. PubMed ID: 2958104 [No Abstract] [Full Text] [Related]
33. Fatal multisystemic toxicity associated with prophylaxis with pyrimethamine and sulfadoxine (Fansidar). Selby CD, Ladusans EJ, Smith PG. Br Med J (Clin Res Ed); 1985 Jan 12; 290(6462):113-4. PubMed ID: 3155635 [No Abstract] [Full Text] [Related]
34. Fansidar-associated fatal reaction in an HIV-infected man. Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep; 1988 Sep 23; 37(37):571-2, 577. PubMed ID: 3137443 [No Abstract] [Full Text] [Related]
35. [Serious side effects of sulfadoxine/pyrimethamine as antimalarials]. Christensen PK, Loft S, Olsen VV. Ugeskr Laeger; 1983 Jan 24; 145(4):245. PubMed ID: 6845486 [No Abstract] [Full Text] [Related]
36. Liver damage associated with fansidar. Wejstal R, Lindberg J, Malmvall BE, Norkrans G. Lancet; 1986 Apr 12; 1(8485):854-5. PubMed ID: 2870335 [No Abstract] [Full Text] [Related]
37. Does chloroquine contribute to the risk of serious adverse reactions to fansidar? Rombo L, Stenbeck J, Lobel HO, Campbell CC, Papaioanou M, Miller KD. Lancet; 1985 Dec 07; 2(8467):1298-9. PubMed ID: 2866354 [No Abstract] [Full Text] [Related]
38. Fatal toxic epidermal necrolysis during prophylaxis with pyrimethamine and sulfadoxine in a human immunodeficiency virus-infected person. Raviglione MC, Dinan WA, Pablos-Mendez A, Palagiano A, Sabatini MT. Arch Intern Med; 1988 Dec 07; 148(12):2683-5. PubMed ID: 3264143 [Abstract] [Full Text] [Related]